Lipigon Pharmaceuticals AB (FRA:9RP) Short Percentage of Float


What is Lipigon Pharmaceuticals AB Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:9RP vs VRTX, REGN, ALNY: Short Percentage of Float Comparison

For the Biotechnology subindustry, Lipigon Pharmaceuticals AB's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lipigon Pharmaceuticals AB Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lipigon Pharmaceuticals AB's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Lipigon Pharmaceuticals AB's Short Percentage of Float falls into.


Lipigon Pharmaceuticals AB Business Description

Address Tvistevagen 48 C, Umea, SWE, 90736
Lipigon Pharmaceuticals AB develops medicines for diseases caused by disorders of the body's handling of fats. It focuses on orphan drugs for unusual diseases where there is no adequate treatment.